secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIORA THERAPEUTICS, INC. (—)
CIK:        0001580063
Form:       8-K
Filed at:   2022-12-09T23:59:59+00:00
Accession:  0001193125-22-301868
Event type: regulatory
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Biora receives Nasdaq delisting notice for minimum bid price non-compliance
---------------------------------------------------------------------------

- Nasdaq Staff notified Biora on Dec 6, 2022 that it fails to meet the minimum bid price requirement under Listing Rule 5450(a)(1).
- Company will request a hearing before the Nasdaq Hearings Panel, which will stay any further delisting action pending a decision.
- Biora filed a proxy statement on Nov 29 for a Dec 19 special meeting to authorize a reverse stock split (ratio 5:1 to 25:1) as part of a compliance plan.
- There is no immediate impact on trading of common stock (symbol BIOR) while the hearing process is ongoing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1580063/000119312522301868/0001193125-22-301868-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1580063/000119312522301868/d434300d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-301868

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer